# FDA Inspection 1304424 - Cardinal Health, Inc - February 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/cardinal-health-inc/0021303a-8b41-48f4-b287-2593fa23a601
Source feed: FDA_Inspections

> FDA Inspection 1304424 for Cardinal Health, Inc on February 21, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304424
- Company Name: Cardinal Health, Inc
- Inspection Date: 2026-02-21
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 977922 - 2016-05-26](https://www.keypedia.com/records/fda_inspections/cardinal-health-inc/7c2064b4-0c31-4a2b-b58c-589dedfcccb9)
- [FDA Inspection 892549 - 2014-08-18](https://www.keypedia.com/records/fda_inspections/cardinal-health-inc/0fdfd5ce-2f4d-40da-b5f9-7668fdd3b336)
- [FDA Inspection 799530 - 2012-09-17](https://www.keypedia.com/records/fda_inspections/cardinal-health-inc/ca6b7b4f-f09e-4b18-87fa-9023e083b1c3)

Company: https://www.keypedia.com/companies/cardinal-health-inc/2d5c7072-192f-4c99-b62d-10cac97733a0

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9